Deerfield Management’s BlossomHill Therapeutics BLSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$27M Buy
+1,446,000
New +$28.7M 0.42% 52

Other funds holding BLSM

Deerfield Management's BLSM Position: Q3 2026 in Review

Deerfield Management opened a new position in BlossomHill Therapeutics (BLSM) in Q3 2026: 1,446,000 shares worth $27M. The stake represents 0.42% of the portfolio and ranks #52 among its holdings.

39 funds tracked by Wall St. Rank hold BLSM as of Q3 2026.

  • Deerfield Management held 1,446,000 shares of BlossomHill Therapeutics worth $27M as of Q3 2026.
  • BlossomHill Therapeutics was a new Deerfield Management position in Q3 2026.
  • BlossomHill Therapeutics made up 0.42% of Deerfield Management's portfolio in Q3 2026, its #52 holding.
  • 39 funds tracked by Wall St. Rank held BlossomHill Therapeutics as of Q3 2026.

Based on Deerfield Management's 13F filing for Q3 2026, filed 16 Nov 2026.